Paul M Maciocia. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Anti-Inflammatory Agents/pharmacologyAntihypertensive Agents/pharmacologyAtorvastatinC-Reactive Protein/metabolismChemokine CCL2/metabolismHeptanoic Acids/pharmacologyHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyHypertension, Pulmonary/drug therapyHypertension, Pulmonary/immunologyInflammation Mediators/metabolismInterleukin-6/metabolismMuscle, Smooth, Vascular/drug effectsMuscle, Smooth, Vascular/immunologyNF-kappa B/metabolismPulmonary Artery/drug effectsPulmonary Artery/immunologyPyrroles/pharmacology
Substances: See more » Anti-Inflammatory AgentsAntihypertensive AgentsChemokine CCL2Heptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsInterleukin-6NF-kappa BPyrrolesC-Reactive ProteinAtorvastatin
Year: 2010 PMID: 20074252 DOI: 10.1111/j.1755-5922.2009.00128.x
Source DB: PubMed Journal: Cardiovasc Ther ISSN: 1755-5914 Impact factor: 3.023